Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

The key to reversing cellular aging may lie in a protein responsible for toggling cells between a "young" and an "old" state.

GloboCare has received a Notice of Allowance from the China National Intellectual Property Administration for its patent ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the establishment of a new North American team and facilities to advance development ...